Literature DB >> 9544690

Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose.

L A Green1, S S Gambhir, A Srinivasan, P K Banerjee, C K Hoh, S R Cherry, S Sharfstein, J R Barrio, H R Herschman, M E Phelps.   

Abstract

UNLABELLED: The mouse model is currently being explored for various applications with PET imaging. Low resolution of current animal scanners relative to mouse size leads to difficulty in quantitating data from mouse PET images. We have, therefore, investigated methods for determining blood time-activity curves (TACs) from mouse PET studies done with fluorine-18-fluorodeoxyglucose (FDG).
METHODS: Eight mice were fasted, the tail vein was injected with 150-300 microCi of FDG and dynamic images were acquired with a CTI/Siemens (Knoxville, TN) animal tomograph for 64.5 min. Concurrently, 11-14 left ventricle (LV) blood samples were drawn directly from the LV chamber. Organ TACs were obtained by drawing circular regions of interest (ROIs) of various sizes on images of the heart, liver and brain. For each mouse, the FDG model parameter K = (K1 x k3)/(k2 + k3) was estimated by a Patlak algorithm with various estimates of the blood TAC and, as a reference tissue TAC, the brain TAC.
RESULTS: Most partial-volume-corrected heart ROI TACs overestimated the LV samples. Blood TACs from heart images produced statistically different estimates of K than did the LV samples. The liver image-derived blood TACs yielded estimates of K that were comparable to those yielded by the LV samples. Estimates of K determined with two directly sampled LV points in conjunction with the liver image-derived TAC were not statistically different from the estimates obtained with the LV samples. The size and location of ROIs on images of the liver minimally affected the TACs.
CONCLUSION: We have shown that it is experimentally possible to obtain a blood TAC from mouse studies by repeatedly sampling from the LV. We have also shown that images of the liver can be used to reliably estimate the blood TAC. Future FDG PET studies with the mouse model will benefit from this demonstrated ability to noninvasively quantitate blood TACs directly from FDG PET images.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544690

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with (99m)Tc- and (123)I-labelled probes.

Authors:  M Pissarek; J Meyer-Kirchrath; T Hohlfeld; S Vollmar; A M Oros-Peusquens; U Flögel; C Jacoby; U Krügel; N Schramm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-07       Impact factor: 9.236

2.  Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.

Authors:  Thomas O'Brien; Jason Oeh; Yang Xiao; Xiaorong Liang; Alexander Vanderbilt; Ann Qin; Lulu Yang; Leslie B Lee; Justin Ly; Ely Cosino; Jennifer A LaCap; Annie Ogasawara; Simon Williams; Michelle Nannini; Bianca M Liederer; Peter Jackson; Peter S Dragovich; Deepak Sampath
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.

Authors:  A Michael Peters; Georgia Keramida; Deborah Pencharz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-17       Impact factor: 9.236

Review 4.  Quantitative assessment of dynamic PET imaging data in cancer imaging.

Authors:  Mark Muzi; Finbarr O'Sullivan; David A Mankoff; Robert K Doot; Larry A Pierce; Brenda F Kurland; Hannah M Linden; Paul E Kinahan
Journal:  Magn Reson Imaging       Date:  2012-07-21       Impact factor: 2.546

5.  Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

Authors:  Georgia Keramida; Sabina Dizdarevic; Janice Bush; A Michael Peters
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

6.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography.

Authors:  S S Gambhir; J R Barrio; M E Phelps; M Iyer; M Namavari; N Satyamurthy; L Wu; L A Green; E Bauer; D C MacLaren; K Nguyen; A J Berk; S R Cherry; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection.

Authors:  Ruedi K Braun; Melanie Molitor-Dart; Christopher Wigfield; Zhuzai Xiang; Sean B Fain; Ewa Jankowska-Gan; Christine M Seroogy; William J Burlingham; David S Wilkes; David D Brand; Jose Torrealba; Robert B Love
Journal:  Transplantation       Date:  2009-12-27       Impact factor: 4.939

8.  Improved derivation of input function in dynamic mouse [18F]FDG PET using bladder radioactivity kinetics.

Authors:  Koon-Pong Wong; Xiaoli Zhang; Sung-Cheng Huang
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

9.  Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET.

Authors:  Amy S Yu; Hong-Dun Lin; Sung-Cheng Huang; Michael E Phelps; Hsiao-Ming Wu
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

10.  Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery.

Authors:  Ian Y Chen; Joseph C Wu; Jung-Jun Min; Gobalakrishnan Sundaresan; Xiaoman Lewis; Qianwa Liang; Harvey R Herschman; Sanjiv S Gambhir
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.